Literature DB >> 10779168

Human gene marker/therapy clinical protocols.

S A Rosenberg, R M Blaese, M K Brenner, A B Deisseroth, F D Ledley, M T Lotze, J M Wilson, G J Nabel, K Cornetta, J S Economou, S M Freeman, S R Riddell, M Brenner, E Oldfield, B Gansbacher, C Dunbar, R E Walker, F G Schuening, J A Roth, R G Crystal, M J Welsh, K Culver, H E Heslop, J Simons, R W Wilmott, R C Boucher, H F Siegler, J A Barranger, S Karlsson, D Kohn, J E Galpin, C Raffel, C Hesdorffer, J Ilan, P Cassileth, J O'Shaughnessy, L E Kun, T K Das, F Wong-Staal, R E Sobol, R Haubrich, M Sznol, J Rubin, E J Sorcher, J Rosenblatt, R Walker, K Brigham, N Vogelzang, E Hersh, S L Eck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10779168     DOI: 10.1089/10430340050015536

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  6 in total

Review 1.  Gene therapy for Fabry disease.

Authors:  C Siatskas; J A Medin
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

2.  Transduction of an IL-2 gene into human melanoma-reactive lymphocytes results in their continued growth in the absence of exogenous IL-2 and maintenance of specific antitumor activity.

Authors:  K Liu; S A Rosenberg
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

3.  Regulation of herpes simplex virus gamma(1)34.5 expression and oncolysis of diffuse liver metastases by Myb34.5.

Authors:  Hideo Nakamura; Hideki Kasuya; John T Mullen; Sam S Yoon; Timothy M Pawlik; Soundararajalu Chandrasekhar; James M Donahue; E Antonio Chiocca; Richard Y Chung; Kenneth K Tanabe
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

Review 4.  Nanovehicular intracellular delivery systems.

Authors:  Ales Prokop; Jeffrey M Davidson
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

5.  DNA as therapeutics; an update.

Authors:  P Saraswat; R R Soni; A Bhandari; B P Nagori
Journal:  Indian J Pharm Sci       Date:  2009-09       Impact factor: 0.975

6.  Regulation of herpes simplex virus 1 replication using tumor-associated promoters.

Authors:  John T Mullen; Hideki Kasuya; Sam S Yoon; Nancy M Carroll; Timothy M Pawlik; Soundararajalu Chandrasekhar; Hideo Nakamura; James M Donahue; Kenneth K Tanabe
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.